Skip to Content

A 139 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint A 139 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Alembic Pharmaceuticals Inc..

Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A 139

Fenofibric acid delayed-release 135 mg A 139

Fenofibric Acid Delayed-Release

Imprint:
A 139
Strength:
135 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alembic Pharmaceuticals Inc.
National Drug Code (NDC):
62332-0245

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide